The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer

Br J Cancer. 2017 Oct 10;117(8):1113-1120. doi: 10.1038/bjc.2017.283. Epub 2017 Aug 31.

Abstract

Background: There are over half a million women with a previous breast cancer diagnosis living in the UK. It is important to establish their level of unmet physical and psychosocial needs, as many are not routinely seen for follow-up under current models of care.

Methods: We conducted a retrospective analysis of early breast cancer survivors entering an Open Access Follow-Up (OAFU) programme in 2015. Unmet needs were assessed using the Holistic Needs Assessment (HNA) or extracted directly from the electronic patient record (EPR), when the HNA had not been completed.

Results: Six hundred and twenty-five patients were eligible. Sixty-one per cent of the survivors had at least one unmet need and 18% had ⩾5 needs. Consistently higher levels of unmet needs were identified using the formal HNA checklist as opposed to extraction from EPR (P<0.001). Physical and emotional needs were the most frequently reported (55 and 24% respectively). Patients receiving endocrine therapy and those who had received chemotherapy were more likely to report unmet needs (both P<0.001).

Conclusions: Unmet physical and emotional needs are common in breast cancer survivors. It is vital that the services are available for these patients as they transition from hospital-based follow-up to patient-led self-management models of care.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Anxiety / psychology
  • Breast Neoplasms / pathology
  • Breast Neoplasms / physiopathology*
  • Breast Neoplasms / psychology
  • Breast Neoplasms / therapy
  • Depression / psychology
  • Electronic Health Records
  • Fatigue / physiopathology
  • Female
  • Hot Flashes / physiopathology
  • Humans
  • Logistic Models
  • Middle Aged
  • Multivariate Analysis
  • Needs Assessment*
  • Neoplasm Staging
  • Pain / physiopathology
  • Retrospective Studies
  • Risk Factors
  • Sleep Wake Disorders / physiopathology
  • Social Support
  • Surveys and Questionnaires
  • Survivors*
  • United Kingdom

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal